Trametinib for patients with advanced melanoma

Lancet Oncol. 2012 Oct;13(10):e409; author reply e409-10. doi: 10.1016/S1470-2045(12)70419-9.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Female
  • Humans
  • MAP Kinase Kinase 1 / antagonists & inhibitors*
  • MAP Kinase Kinase 2 / antagonists & inhibitors*
  • Male
  • Melanoma / drug therapy*
  • Protein Kinase Inhibitors / administration & dosage*
  • Pyridones / administration & dosage*
  • Pyrimidinones / administration & dosage*
  • Skin Neoplasms / drug therapy*
  • Uveal Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • Pyridones
  • Pyrimidinones
  • MAP Kinase Kinase 1
  • MAP Kinase Kinase 2